The purpose of this study was to clarify the effect of Bovine leukemia virus (BLV) infection on natural immunity in the bovine mammary gland and on the severity of clinical mastitis. We classified milk samples from clinical mastitic cows into BLV-positive (n=76) and BLV-negative (n=12). BLV-positive cows were further divided into cows with High BLV proviral load (H-PVL) (n=23) and Low BLV proviral load (L-PVL) (n=53). Severity of clinical mastitis was classified as MILD, MODERATE, or SEVERE. Multiple logistic regression analysis was performed on the host factors and environmental factors with severity of clinical mastitis as the objective variable. BLV proviral load (PVL) and season at onset of mastitis showed significant correlation with the severity of clinical mastitis. Binary logistic regression analysis was performed on natural immunity factors lactoferrin and lingual antimicrobial peptide (LAP) concentration in milk, with PVL as the objective variable. Of these natural immunity factors, LAP concentration in milk showed significant correlation with PVL. The results of the present study suggested that PVL and season are associated with severity of clinical mastitis, and that the immune function in the mammary gland is decreased in cows with H-PVL compared to that in cows with L-PVL.
treatment, and impedes milk delivery due to increases in somatic cell count (SCC) [6, 11] . Particularly, it is reported that severe mastitis causes significantly reduced milk production and requires complex treatment (using multiple antibiotics) compared to mild mastitis [37] . The causes of mastitis vary widely [11] ; consistently, however, infection of the mammary gland results in the rapid accumulation of neutrophils, lactoferrin (LF), β-lactoglobulin, and defensin, all of which have been reported to be significant host factors for the disease [45, 46] . The cells that contribute to the SCC include neutrophils that enter the mammary gland in response to mammary infection and mammary gland epithelial cells that are shed into the milk. As a result, the SCC serves as an important indicator of the inflammatory response due to intramammary infection [7, 42] . Recently, it has been reported that the lingual antimicrobial peptide (LAP), a member of the β-defensin family of peptides, is secreted from mammary epithelial cells into the milk [19, 23] , and it is known that LAP in milk exhibits nonspecific activity against many kinds of bacteria and viruses, potentially resulting in bacteriolysis [24] . Similarly, LF, an iron-binding glycoprotein, is known to inhibit bacterial growth [2, 12] ; LF is synthesized by mammary epithelial cells and neutrophils before being secreted into the milk [4, 20] . Recently, increases in parity have been reported to correlate with decreases, in milk, of LF concentrations [17] and lactoperoxidase (LPO) activity [25] . Thus, host factors appear to play a large role in innate immunity.
There have been several reports on the relationship between BLV infection and clinical mastitis, including reports that the incidence of subclinical mastitis is higher in cows with persistent lymphocytosis (PL) [41] , and that the SCC is elevated in cows with EBL, presumably reflecting the immunosuppressive effect of BLV infection [10, 40] . Economic loss due to changes in milk production from BLV infection is being brought to attention. Therefore, investigation of the economic losses associated with both mastitis and BLV infection is essential in better understanding the impact of infectious disease on the dairy industry economy. However, the effect of BLV infection on the severity of clinical mastitis during lactation, including the relationship between PVL and the severity of clinical mastitis, has not (to our knowledge) previously been reported.
Thus, the purpose of the present study was to clarify the effect of BLV infection on natural immunity in the bovine mammary gland and on the severity of clinical mastitis.
MATERIALS AND METHODS

Cows
Milk samples were collected from a total of 88 quarters from 88 lactating Holstein-Friesian dairy cows with clinical mastitis. The cows were located on 2 farms in Saitama Prefecture. Sampling was performed from March 2016 to April 2017. Mastitic cows were identified by clinical evaluation and diagnosis by a veterinarian. On the day of onset of mastitis, milk samples were collected aseptically from each cow, and peripheral blood was collected from the tail vein using EDTA-2Na-containing vacuum blood collection tubes. The collected milk was assessed by bacterial culture test and SCC was measured before storage of the milk at −80°C pending measurement of LF and LAP concentrations. Blood was used for BLV detection tests, which were performed by quantitative PCR.
Severity of clinical mastitis
The severity of clinical mastitis was defined according to the existing classification method [5, 8, 39] . In short, the severity at the onset of clinical mastitis was classified as MILD (those with milk abnormalities such as clots in milk, significant milk reduction, high SCC, and discoloration), MODERATE (those with milk abnormalities and udder abnormalities such as swelling and hardness), or SEVERE (those with milk abnormalities, udder abnormalities and general symptoms such as fever, general depression and anorexia). For cows with clinical mastitis in multiple quarters, the quarter with the highest detected bacterial count was selected.
Bacterial culture from milk
Milk samples were cultured on 5% sheep blood agar, and the bacteria present in milk samples were identified according to the procedure described by the National Mastitis Council [18] .
Measurement of SCC in milk
SCC was performed as previously described [29] . Specifically, milk was diluted 10-fold with sterile saline (100 µl of milk + 900 µl of saline) and cells were quantified using a DeLaval cell counter (DeLaval International AB, Tumba, Sweden).
Measurement of LF concentration in milk
The LF in milk was measured using a single radial immunodiffusion kit (MCC: Mitsumaru Chemical Co., Ltd., Shibata-gun, Japan).
Measurement of LAP concentration in milk
Milk fat was removed by centrifugation at 1,700× g for 30 min at 4°C. The concentration of LAP in skim milk was measured as previously described [23] . Briefly, a 96-well microtiter plate was coated with 2 µg/ml anti-LAP antibody in carbonate buffer (pH 9.7) at 4°C overnight; this step was followed by blocking with 0.05 M borate buffer supplemented with 0.2% bovine serum albumin at pH 7.8. Skim milk samples were diluted 10-fold with borate buffer. Equal volumes (0.05 ml each) of the 10-fold diluted skim milk and horseradish peroxidase-labeled LAP [23] were pipetted into wells followed by incubation for 3 hr at room temperature. After washing four times with phosphate-buffered saline, the wells were incubated with 0.15 ml of tetramethyl benzidine solution for 30 min. The optical density was measured at a wavelength of 655 nm using Multiskan FC (Thermo Fisher Scientific, Tokyo, Japan). Assays were performed in duplicate. The sensitivity and recovery of LAP were 0.04 nM and 100-115%, respectively. The coefficients of variation for intra-and interassay variation were 6.5 and 13.5%, respectively.
Quantitative PCR (qPCR) for BLV
As described previously [32] , qPCR to quantify viral and proviral BLV genome levels was performed for all samples using the 7500 Real-Time PCR system (Applied Biosystems, Foster City, CA, U.S.A.). The primers 5′-GGACAAATGGACTGCTCAAAC-3′ and 5′-CTCCCATCTGGTCTTTAGAATTG-3′ and the probe 5′-FAM-CTTCCCATGACTCAGGCCCTTTCT-TAM-3′ were used to measure proviral load in BLV cattle and viral copy number in the supernatant of clone-transfected HeLa cells. The primer and probe used in this study were designed to target the highly conserved gene region encoding BLV polymerase (The GenBank accession numbers are LC164083, LC164084, LC164085, and LC164086). A standard curve was generated using serial dilutions of pBLV-FLK as the template, and the viral copy number was calculated.
Diagnosis and classification of BLV status
If a PVL was detected by PCR, the sample was defined as BLV positive; if PVL was not detected by PCR, the sample was defined as BLV negative [47] . Among the BLV-positive cows, animals harboring a PVL of ≥1,000 copies / 10 ng DNA were classified as H-PVL cows; animals harboring a PVL of <1,000 copies / 10 ng DNA were classified as L-PVL cows.
Statistical analysis
Fisher's exact test was used to compare pathogens between BLV positive and negative groups. The host factors (age, days in milk, teat-end score, PVL, and concurrent disease) and environmental factors (farm and season at onset of mastitis) were individually analyzed by univariate analysis to identify the factors that had effects on the severity of clinical mastitis. The Kruskal-Wallis test was used to analyze numerical values (age, days in milk) and the Fisher's exact test was used to analyze nominal values (PVL, concurrent disease, farm, and season at onset of mastitis). Variables with P<0.2 in the univariate analysis were selected as explanatory variables, severity of clinical mastitis was selected as the objective variable, and multiple logistic regression analysis was performed.
To investigate the relationship between PVL and natural immunity factors at the onset of mastitis, the Wilcoxon rank-sum test was used for univariate analysis to analyze PVL against SCC in milk, LAP concentration in milk, and LF concentration in milk. Variables with P<0.2 were selected as explanatory factors, PVL was selected as the objective variable, and binary logistic regression analysis was performed by the "forced entry" method. A probability of P<0.05 was considered significant. IBM SPSS Statistics 22.0 software (International Business Machines Co., Ltd., New York, NY, U.S.A.) was used for all statistical analysis.
RESULTS
Summary and comparison of severity of clinical mastitis between BLV-positive cows and BLV-negative cows at first onset
Out of the 88 cows used for this experiment, the PCR method detected PVL at the onset of clinical mastitis in 76 quarters from 76 cows; therefore, these animals were defined as BLV-positive cows. No PVL was detected in 12 quarters from 12 cows; therefore, these animals were defined as BLV-negative cows. Additionally, Streptococci (31/88), Coagulase-negative-staphylococci (14/88), Staphylococcus aureus (14/88), Coliform (4/88), Corynebacterium bovis (3/88), Yeast (1/88), Prototheca zopfii (1/88) were isolated from 88 milk samples; however, no significant difference was found in the detection rate of pathogens between BLVpositive and BLV-negative cows (data not shown). 18 samples were no growth and 2 samples were contamination.
Host factors associated with severity of clinical mastitis
Univariate analysis of individual factors and severity of clinical mastitis (Table 1) identified four factors (days in milk, PVL, farm, and season at onset of mastitis) for inclusion in the multiple logistic regression analysis. Of those factors, PVL (P=0.0029, odds ratio=5.396) and season at onset of mastitis (spring: P=0.0011, odds ratio=28.167; summer: P=0.009, odds ratio=81.732; autumn: P=0.024, odds ratio=23.383) showed significant correlation with the severity of clinical mastitis ( Table 2 ).
Relationship of PVL to natural immunity factors in milk at onset of mastitis
Within the BLV-positive group, 23 quarters were H-PVL and 53 quarters were L-PVL. Univariate analysis of each factor and PVL (Table 3 ) identified two factors (LF concentration, and LAP concentration in milk) for inclusion in the binary logistic regression analysis (Table 4 ). Of these natural immunity factors, LAP concentration in milk showed significant correlation with PVL (P=0.023, odds ratio=0.89).
DISCUSSION
Results from our multiple regression analysis suggested that PVL and season at onset of mastitis are strongly correlated with the severity of clinical mastitis. The results showed that development of severe clinical mastitis was observed 23.383 times more frequently in spring, 81.732 times more frequently in summer, and 23.383 times more frequently in autumn compared with cases of mild clinical mastitis during the respective season. It has been reported that SCC increases in summer [9] , suggesting that season at onset of clinical mastitis is associated with severity of clinical mastitis. In addition to season at onset of mastitis, factors such as age, teat-end score, and bacterial presence previously have been reported to be involved in the severity of clinical mastitis [11] . The present report did not reveal a significant role for these specific factors in the severity of clinical mastitis; however, with development of severe clinical mastitis, PVL was observed 5.396 times more frequently compared to development of mild clinical mastitis. This observation suggested that there is a relationship between severity of clinical mastitis and BLV infection.
Other studies have reported that BLV-infected cows with PL have high PVLs [1, 43] and increased incidence of mastitis [41] . Our results suggested that PVL is significantly associated with the severity of clinical mastitis. We presume that cows with PL were categorized in the H-PVL group in our study. Given that animals with more-severe clinical mastitis may exhibit delayed recovery, it may be necessary to reassess the methods and compounds used for treatment of these cows.
The effect of BLV infection on innate immunity of the mammary gland remains poorly characterized. It has been reported that the progression of severity in clinical mastitis is largely dependent on innate immune function at the onset of mastitis [44] ; therefore, we expected that blood BLV PVL and innate immunity in the mammary gland would show correlation. Our results showed that there is a relationship between PVL and LAP in milk. It is known that LAP in milk attacks many kinds of bacteria or viruses nonspecifically, and can be a cause of bacteriolysis [24] . It has been reported that type-17 T helper (Th17) cells, which are a subset of CD4 + effector T cells, secrete antimicrobial peptides when in proximity to epithelial cells; Th17 cells also have been shown to induce proliferation and mobilization of neutrophils, and to proliferate with progression of disease in the mammary gland of mice with mastitis [34, 48] . In BLV-positive cows, the expression of PD-1 and PD-L1 is enhanced and immune exhaustion of effector cells has been observed [21, 22] . Therefore, we hypothesize that LAP expression in mammary epithelium may have been suppressed in H-PVL cows. Our results did not show any relationship between PVL and SCC in milk. There remains the possibility that SCC in milk in both H-PVL and L-PVL cows may have shown to be even higher without BLV infection, and it is difficult to determine the actual degree of decrease of SCC in milk in both H-PVL and L-PVL cows. Our results did not show any relationship between PVL and LF in milk. It has been reported that LF concentration in milk after development of clinical mastitis becomes lower with occurrence of severe mastitis at onset [28] , and that comparatively with LAP concentration in milk increasing immediately after onset, LF in milk increases 12 hr after occurrence of clinical mastitis [19, 30] . In this study, we used milk samples collected immediately after occurrence, which suggested the possibility that results reflect values before LF in milk had increased.
The results of the present study suggested that PVL and season are associated with severity of clinical mastitis, and that the immune function of epithelial cells in the mammary gland is decreased in cows with H-PVL compared to that in cows with L-PVL. Recent evidence indicates the value of identifying BLV-positive cows based on the level of the PVL [31, 43] . We believe that the results of our study further support the importance of tracking BLV-positive cows with H-PVL within the herd. At onset of mastitis, we believe there is a need to treat clinical mastitis taking into account the likely decreases in immune system function in the mammary glands of BLV-positive cows. However, it appears that not only PVL but also season at onset of clinical mastitis is strongly associated with severity of clinical mastitis, suggesting that it is necessary to consider not only BLV infection, but also factors other than BLV infection, in investigating the severity of clinical mastitis. 
